Pharmabiz

Johnson & Johnson announces positive results from phase 3 MajesTEC-9 study of Tecvayli in patients with multiple myeloma

Johnson & Johnson, a worldwide leader in multiple myeloma therapies, announced positive topline results from the investigational phase 3 MajesTEC-9 study of Tecvayli (teclistamab-cqyv) monotherapy, ...
Pharmabiz

Novo Nordisk Foundation grants DKK 5.5 billion to BioInnovation Institute to elevate innovation in Denmark and Europe

Novo Nordisk Foundation grants DKK 5.5 billion to BioInnovation Institute to elevate innovation in Denmark and Europe: Denmark Friday, January 16, 2026, 09:00 Hrs [IST] The Novo N ...
Pharmabiz

IPC registers 44 small-scale medtech firms under ADRMS for reporting medical devices related SAEs

IPC registers 44 small-scale medtech firms under ADRMS for reporting medical devices related SAEs: Shardul Nautiyal, Mumbai Friday, January 16, 2026, 08:00 Hrs [IST] The Indian Ph ...
Pharmabiz

Diagnostics & healthcare flag medical infrastructure, tech adoption as critical priorities in Union Budget 2026

Diagnostics & healthcare flag medical infrastructure, tech adoption as critical priorities in Union Budget 2026: Nandita Vijayasimha, Bengaluru Friday, January 16, 2026, 08:00 Hrs ...
Pharmabiz

Single-cell research of patients’ immune cells to guide future treatments: Dr Arivusudar John

Single-cell research of patients’ immune cells to guide future treatments: Dr Arivusudar John: Shardul Nautiyal, Mumbai Friday, January 16, 2026, 08:00 Hrs [IST] Single-Cell Ana ...
Pharmabiz

Delhi and Pondicherry join nationwide crackdown on toxic Almont-Kid paediatric syrup

Delhi and Pondicherry join nationwide crackdown on toxic Almont-Kid paediatric syrup: Peethaambaran Kunnathoor, Chennai Friday, January 16, 2026, 08:00 Hrs [IST] The drug control ...
Pharmabiz

Panel asks Ministry of Ayush to conduct comprehensive revision of curricula in Ayush streams

The Parliamentary Panel on Health and Family Welfare has urged the Ministry of Ayush to conduct a comprehensive revision of curricula across all Ayush streams to modernise and integrate latest ...
Pharmabiz

DY Patil School of Law and the Institute of Medicine & Law sign MoU to strengthen medico-legal education

DY Patil School of Law and the Institute of Medicine & Law sign MoU to strengthen medico-legal education: Our Bureau, Mumbai Thursday, January 15, 2026, 17:15 Hrs [IST] D Y Patil ...
Pharmabiz

ScreenPoint Medical & Ferrum Health partner to offer Transpara Breast AI through Ferrum’s AI Governance Suite

ScreenPoint Medical & Ferrum Health partner to offer Transpara Breast AI through Ferrum’s AI Governance Suite: San Francisco Thursday, January 15, 2026, 18:00 Hrs [IST] ScreenPo ...
Pharmabiz

Alamar Biosciences launches NULISAqpcr AD 5-plex assay to advance blood-based biomarker detection in Alzheimer’s disease

Alamar Biosciences launches NULISAqpcr AD 5-plex assay to advance blood-based biomarker detection in Alzheimer’s disease: Fremont, California Thursday, January 15, 2026, 16:00 H ...
Pharmabiz

Boehringer Ingelheim begins phase IIa trial of BI 765423, a novel monoclonal antibody targeting IL-11, in patients with idiopathic pulmonary fibrosis

Boehringer Ingelheim begins phase IIa trial of BI 765423, a novel monoclonal antibody targeting IL-11, in patients with idiopathic pulmonary fibrosis: Ingelheim, Germany Thursday, ...
Pharmabiz

Shift to large molecules and AI-led transformation to accelerate, CRDMOs to grow in 2026: EY Parthenon India

Our Bureau, New Delhi Thursday, January 15, 2026, 16:30 Hrs [IST] ...